News

Pfizer Inc. (NYSE:PFE) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. Pfizer Inc. (NYSE:PFE) hasn’t performed well in recent years, with its stock declining more than 26% ...
Bristol-Myers Squibb and Pfizer announce a 43% discount on Eliquis for uninsured U.S. patients, challenging traditional drug pricing models.
The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company delayed the results of COVID-19 vaccine trials to influence the 2020 election.
A former Pfizer scientist was subpoenaed Monday by House Republicans over allegations that there was a conspiracy among senior executives at the pharma company to “deliberately slow down&#822… ...
Pfizer Inc. has initiated a new clinical study titled A Phase 1, Randomized, Double Blind, Sponsor-Open, Placebo-Controlled, Single Dose Escalation Study to Evaluate the Safety, Tolerability, and ...
Is Pfizer’s hefty 7% dividend yield safe? Undoubtedly, the name has encountered its fair share of pressures of late. And while the dividend is getting quite stretched, it’s not necessarily at ...
Recipients of the Pfizer mRNA vaccine experienced more all-cause deaths within the first 100 days post-vaccination than those who received the Moderna shot, a new study of 1.47 million people found.
Pfizer's Depo-Provera shot has been linked to brain tumors — and hundreds of women are suing the pharmaceutical giant over it.
Braftovi, acquired in Pfizer’s $10.6 billion buyout of Array BioPharma in 2019, has been steadily growing, winning approvals to treat patients with skin, lung and colorectal cancer whose tumors ...